Neurological Disorder Diagnostics Market: By Component (Instruments, Reagents, and Kits, Software, and Services), By Technology (Immunoassay, PCR Techniques), By Disease Type (Alzheimers disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Others), By End User (Hospitals and Clinics, Diagnostic Centers, Academic, and Research Institutes), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Neurological Disorder Diagnostics Market size was valued at USD x million in 2022 and is poised to grow at a CAGR of X% from 2023-2029

Global Neurological Disorder Diagnostics Market Summary

Study Period

2023-2029

Base Year

2023

CAGR

x%

Largest Market

N/A

Fastest Growing Market

N/A

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Neurological Disorder Diagnostics Market Segmentation

By Component
  • Instruments
  • Reagents
  • Kits
  • Software
  • Services
By Technology
  • Immunoassay
  • PCR Techniques
By Disease Type
  • Alzheimer's Sisease
  • Dementia
  • Parkinson's Disease
  • Epilepsy
  • Traumatic Brain Injury
  • Others
By End User
  • Hospitals
  • Clinics, Diagnostic Centers
  • Academic
  • Research Institutes

Frequently Asked Questions

The neurological disorder diagnostics market key players are: Hoffmann La Roche Ltd., Creative Biolabs, Diadem Srl, Fujirebio Diagnostics, Quest Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary    
2. Global Neurological Disorder Diagnostics Market Introduction    
2.1. Global Neurological Disorder Diagnostics Market Taxonomy    
2.2. Global Neurological Disorder Diagnostics Market Definitions    
2.2.1. By Component    
2.2.2. By Technology    
2.2.3. By Disease Type    
2.2.4. By End User    
2.2.5. By Region    
3. Global Neurological Disorder Diagnostics Market Dynamics    
3.1. Drivers    
3.2. Restraints    
3.3. Opportunities/Unmet Needs of the Market    
3.4. Trends    
3.5. Global Neurological Disorder Diagnostics Market Dynamic Factors - Impact Analysis    
3.6. Global Neurological Disorder Diagnostics Market Competition Landscape    
3.7. Epidemiology    
4. Global Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029    
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)    
4.3. Market Opportunity Analysis    
5. Global Neurological Disorder Diagnostics Market, By Component, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
5.1. Instruments    
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
5.1.3. Market Opportunity Analysis    
5.2. Reagents and Kits    
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
5.2.3. Market Opportunity Analysis    
5.3. Software and Services    
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
5.3.3. Market Opportunity Analysis    
6. Global Neurological Disorder Diagnostics Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
6.1. Immunoassay    
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
6.1.3. Market Opportunity Analysis    
6.2. PCR Techniques    
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
6.2.3. Market Opportunity Analysis    
7. Global Neurological Disorder Diagnostics Market, By Disease Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.1. Alzheimers Disease    
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
7.1.3. Market Opportunity Analysis    
7.2. Dementia    
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
7.2.3. Market Opportunity Analysis    
7.3. Parkinson's Disease    
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
7.3.3. Market Opportunity Analysis    
7.4. Epilepsy    
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
7.4.3. Market Opportunity Analysis    
7.5. Traumatic Brain Injury    
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
7.5.3. Market Opportunity Analysis    
7.6. Others    
7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
7.6.3. Market Opportunity Analysis    
8. Global Neurological Disorder Diagnostics Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
8.1. Hospitals and Clinics    
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
8.1.3. Market Opportunity Analysis    
8.2. Diagnostic Centers    
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
8.2.3. Market Opportunity Analysis    
8.3. Academic and Research Institutes    
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
8.3.3. Market Opportunity Analysis    
9. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
9.1. North America    
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
9.1.3. Market Opportunity Analysis    
9.2. Europe    
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
9.2.3. Market Opportunity Analysis    
9.3. Asia-Pacific    
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
9.3.3. Market Opportunity Analysis    
9.4. Latin America    
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
9.4.3. Market Opportunity Analysis    
9.5. Middle East and Africa    
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)    
9.5.3. Market Opportunity Analysis    
9.6. Global Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Technology, By Disease Type, By End User, and Region, 2023 - 2029
10. North America Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
10.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
10.1.1. Instruments    
10.1.2. Reagents and Kits    
10.1.3. Software and Services    
10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
10.2.1. Immunoassay    
10.2.2. PCR Techniques    
10.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
10.3.1. Alzheimers Disease    
10.3.2. Dementia    
10.3.3. Parkinson's Disease    
10.3.4. Epilepsy    
10.3.5. Traumatic Brain Injury    
10.3.6. Others    
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
10.4.1. Hospitals and Clinics    
10.4.2. Diagnostic Centers    
10.4.3. Academic and Research Institutes    
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)    
10.5.1. USA    
10.5.2. Canada    
10.6. North America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029
10.7. North America Neurological Disorder Diagnostics Market Dynamics Trends    
11. Europe Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
11.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
11.1.1. Instruments    
11.1.2. Reagents and Kits    
11.1.3. Software and Services    
11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
11.2.1. Immunoassay    
11.2.2. PCR Techniques    
11.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
11.3.1. Alzheimers Disease    
11.3.2. Dementia    
11.3.3. Parkinson's Disease    
11.3.4. Epilepsy    
11.3.5. Traumatic Brain Injury    
11.3.6. Others    
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
11.4.1. Hospitals and Clinics    
11.4.2. Diagnostic Centers    
11.4.3. Academic and Research Institutes    
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)    
11.5.1. Germany    
11.5.2. UK    
11.5.3. France    
11.5.4. Spain    
11.5.5. Italy    
11.5.6. Russia    
11.5.7. Rest of Europe    
11.6. Europe Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029
11.7. Europe Neurological Disorder Diagnostics Market Dynamics Trends    
12. Asia-Pacific Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
12.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
12.1.1. Instruments    
12.1.2. Reagents and Kits    
12.1.3. Software and Services    
12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
12.2.1. Immunoassay    
12.2.2. PCR Techniques    
12.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
12.3.1. Alzheimers Disease    
12.3.2. Dementia    
12.3.3. Parkinson's Disease    
12.3.4. Epilepsy    
12.3.5. Traumatic Brain Injury    
12.3.6. Others    
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
12.4.1. Hospitals and Clinics    
12.4.2. Diagnostic Centers    
12.4.3. Academic and Research Institutes    
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)    
12.5.1. China    
12.5.2. India    
12.5.3. Japan    
12.5.4. ASEAN    
12.5.5. Australia & New Zealand    
12.5.6. Rest of Asia-Pacific    
12.6. Asia-Pacific Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, by Disease Type, By End User, and Country, 2023 - 2029
12.7. Asia-Pacific Neurological Disorder Diagnostics Market Dynamics Trends    
13. Latin America Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
13.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
13.1.1. Instruments    
13.1.2. Reagents and Kits    
13.1.3. Software and Services    
13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
13.2.1. Immunoassay    
13.2.2. PCR Techniques    
13.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
13.3.1. Alzheimers Disease    
13.3.2. Dementia    
13.3.3. Parkinson's Disease    
13.3.4. Epilepsy    
13.3.5. Traumatic Brain Injury    
13.3.6. Others    
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
13.4.1. Hospitals and Clinics    
13.4.2. Diagnostic Centers    
13.4.3. Academic and Research Institutes    
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)    
13.5.1. Brazil    
13.5.2. Mexico    
13.5.3. Rest of Latin America    
13.6. Latin America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029
13.7. Latin America Neurological Disorder Diagnostics Market Dynamics Trends    
14. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)    
14.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
14.1.1. Instruments    
14.1.2. Reagents and Kits    
14.1.3. Software and Services    
14.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)    
14.2.1. Immunoassay    
14.2.2. PCR Techniques    
14.3. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
14.3.1. Alzheimers Disease    
14.3.2. Dementia    
14.3.3. Parkinson's Disease    
14.3.4. Epilepsy    
14.3.5. Traumatic Brain Injury    
14.3.6. Others    
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)    
14.4.1. Hospitals and Clinics    
14.4.2. Diagnostic Centers    
14.4.3. Academic and Research Institutes    
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)    
14.5.1. Gulf CoEnd User Council (GCC) Countries    
14.5.2. South Africa    
14.5.3. Rest of MEA    
14.6. MEA Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2023 - 2029  
14.7. MEA Neurological Disorder Diagnostics Market Dynamics Trends    
15. Competition Landscape    
15.1. Strategic Dashboard of Top Market Players    
15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis)    
15.2.1. F. Hoffmann La Roche Ltd.    
15.2.2. Creative Biolabs    
15.2.3. Diadem Srl    
15.2.4. Fujirebio Diagnostics    
15.2.5. Quest Diagnostics    
15.2.6. Thermo Fisher Scientific, Inc.    
15.2.7. Bio-Rad Laboratories, Inc.    
15.2.8. Siemens Healthineers    
16. Research Methodology    
17. Appendix and Abbreviations    
  • Hoffmann La Roche Ltd.
  • Creative Biolabs
  • Diadem Srl
  • Fujirebio Diagnostics
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers